Tech Company Financing Transactions
Calithera Biosciences Funding Round
Calithera Biosciences, based in San Francisco, secured $40 million from Morgenthaler Ventures, Advanced Technology Ventures and Delphi Ventures.
Transaction Overview
Company Name
Announced On
7/7/2010
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series A
Investors
Morgenthaler Ventures (Lead Investor) (Christopher Christoffersen)
Proceeds Purpose
Specific proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
343 Oyster Point Blvd. 200
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Calithera is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Susan Molineaux
Vice President
Jennifer McNealey
Vice President
Keith Orford
Vice President
Eric Sjogren
Vice President
Sam Whiting
VP - Bus. Development
Curtis Hecht
VP - Bus. Development
Christopher Molineaux
VP - Finance
Stephanie Wong
VP - General Counsel
Sumita Ray
VP - R & D
Frank Parlati
Browse more venture capital transactions:
Prev: 7/7/2010: Uptake Medical venture capital transaction
Next: 7/7/2010: DFINE venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs